Oxycodone Market to Signify Strong Growth by 2022-2028

 

The global oxycodone market is anticipated to grow at a CAGR of 5.0% during the forecast period (2022-2028). Increased usage of oxycodone to treat mild to moderate acute pain following dental procedures, much higher bioavailability of oxycodone compared to morphine, and development of oxycodone formulations to decrease addiction potential are some factors likely to contribute to the market growth. When opposed to immediate-release oxycodone, oxycodone extended-release formula results in delayed oxycodone absorption and thereby has a lesser misuse potential. Another significant factor projected to fuel the market growth includes the increased usage of extended- and controlled-release oral oxycodone formulations to treat moderate to severe pain.

Some of the key players profiled in the study are Johnson & Johnson Services, Inc., Teva Pharmaceuticals Industries Ltd., and Mylan NV, among others.

Oxycodone Market Segmentation:

By Type 

• Long-Acting Oxycodone
• Short-Acting Oxycodone

By Application 

• Hospital Pharmacies
• Retail Pharmacies 
• Others

Geographic Coverage

• North America Market Size and/or Volume
• Latin America Market Size and/or Volume
• Europe Market Size and/or Volume
• Asia-Pacific Market Size and/or Volume
• Rest of the world Market Size and/or Volume

Key questions answered in this report:

• What is the size of the Oxycodone market and what is its expected growth rate?
• What are the primary driving factors that push the Oxycodone Market forward?
• What are the Oxycodone Industry’s top companies?
• What are the different categories that the Oxycodone Market caters to?
• What will be the fastest-growing segment or region?
• In the value chain, what role do essential players play?
• What is the procedure for getting a free copy of the Oxycodone Market sample report and company profiles?